ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,071.17
0.53%
Dow Jones
44,882.13
0.38%
US Dollar vs MXN
20.6574
-0.10%
Brent Oil
76.225
0.23%
Bitcoin
104,567.82
-0.16%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. CureVac NV (CVAC) Cotización

CureVac NV

CureVac NV (CVAC)

NASDAQ
3.82
-0.05
(-1.29%)
Cerrado 31 Enero 3:00PM
Delayed by 15 minutes
3.96
0.14
(3.66%)
Fuera de horario: 6:08PM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
3.96
Postura de Compra
3.75
Postura de Venta
3.99
Volume Operado de la Acción
300,070
3.81 Rango del Día 3.94
2.215 Rango de 52 semanas 5.28
Capitalización de Mercado [m]
886.995M
Precio Anterior
3.87
Precio de Apertura
3.86
Hora
1
@
3.9
Última hora de negociación
Volumen financiero
US$ 1,162,755
Precio Promedio Ponderado
3.8749
Volumen promedio (3 m)
811,502
Acciones en circulación
223,988,675
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-3.29
Beneficio por acción (BPA)
-1.16
turnover
61.71M
Beneficio neto
-260.17M

Acerca de CureVac NV

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-gen... CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-generation COVID-19 vaccine. CureVac's first attempt to develop a COVID-19 vaccine did not have sufficient efficacy data, and its trials were discontinued in October 2021. The company's other pipeline candidates include mRNA vaccines for influenza, rabies, and malaria. Additionally, CureVac is in the early stages of development for oncology and molecular therapies spanning tumors, liver, ocular, and lung diseases. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.curevac.com
Sede
Tubingen, Deu
Fundado
-
CureVac NV is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CVAC. The last closing price for CureVac NV was US$3.87. Over the last year, CureVac NV shares have traded in a share price range of US$ 2.215 to US$ 5.28.

CureVac NV currently has 223,988,675 shares in issue. The market capitalisation of CureVac NV is US$866.84 million. CureVac NV has a price to earnings ratio (PE ratio) of -3.29.

CVAC Últimas noticias

Más noticias

Form 144 - Report of proposed sale of securities

07 Enero 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

07 Enero 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

07 Enero 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

07 Enero 2025
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

12 Noviembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

12 Noviembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

04 Noviembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

04 Noviembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

27 Septiembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

25 Septiembre 2024
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.042-1.049475262374.0024.08993.76513953.87994848CS
40.617.85714285713.3653.3213158194.18611792CS
121.0636.55172413792.952.378115023.54615706CS
260.38.196721311483.6652.376271673.35833646CS
520.267.027027027033.75.282.2158417043.43148176CS
156-14.22-78.217821782218.1820.62.2157317647.3423734CS
260-81.03-95.340628309284.991332.21579919332.27345649CS

CVAC - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de CureVac NV?
El precio actual de las acciones de CureVac NV es US$ 3.96
¿Cuántas acciones de CureVac NV están en circulación?
CureVac NV tiene 223,988,675 acciones en circulación
¿Cuál es la capitalización de mercado de CureVac NV?
La capitalización de mercado de CureVac NV es USD 866.84M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de CureVac NV?
CureVac NV ha negociado en un rango de US$ 2.215 a US$ 5.28 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de CureVac NV?
El ratio precio/beneficio de CureVac NV es -3.29
¿Cuál es el ratio de efectivo a ventas de CureVac NV?
El ratio de efectivo a ventas de CureVac NV es 13.87
¿Cuál es la moneda de reporte de CureVac NV?
CureVac NV presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de CureVac NV?
El último ingresos anual de CureVac NV es EUR 61.71M
¿Cuál es el último beneficio anual de CureVac NV?
El último beneficio anual de CureVac NV es EUR -260.17M
¿Cuál es la dirección registrada de CureVac NV?
La dirección registrada de CureVac NV es FRIEDRICH-MIESCHER-STRASSE 15, TUBINGEN, 72076
¿Cuál es la dirección del sitio web de CureVac NV?
La dirección del sitio web de CureVac NV es www.curevac.com
¿En qué sector industrial opera CureVac NV?
CureVac NV opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
FOXXFoxx Development Holdings Inc
US$ 6.355
(119.90%)
33.52M
BHILBenson Hill Inc
US$ 3.925
(118.06%)
13.52M
TECXTectonic Therapeutic Inc
US$ 55.18
(114.54%)
5.46M
AMODAlpha Modus Holdings Inc
US$ 3.2299
(109.73%)
125.47M
DOMHDominari Holdings Inc
US$ 3.61
(59.03%)
4.24M
CLEUChina Liberal Education Holdings Ltd
US$ 0.149
(-98.08%)
312.2M
CRGXCARGO Therapeutics Inc
US$ 3.39
(-74.30%)
21.39M
TDTHTrident Digital Tech Holdings Ltd
US$ 1.0159
(-58.87%)
2.46M
EVTVEnvirotech Vehicles Inc
US$ 0.338202
(-49.30%)
4.79M
IRWDIronwood Pharmaceuticals Inc
US$ 2.29
(-38.44%)
10.55M
NVDANVIDIA Corporation
US$ 124.65
(0.77%)
394.43M
CLEUChina Liberal Education Holdings Ltd
US$ 0.149
(-98.08%)
312.2M
MGOLMGO Global Inc
US$ 0.1199
(17.90%)
167.92M
SPGCSacks Parente Golf Inc
US$ 0.93
(57.63%)
129.47M
AMODAlpha Modus Holdings Inc
US$ 3.2299
(109.73%)
126.59M

CVAC Discussion

Ver más
TrendTrade2016 TrendTrade2016 2 meses hace
CVAC IN HERE...WHAT A BALANCE SHEET
👍️0
Monksdream Monksdream 5 meses hace
CVAC under $4
👍️0
tw0122 tw0122 8 meses hace
There is a cure again
👍️0
Monksdream Monksdream 9 meses hace
CVAC new 52 week low
👍️0
Monksdream Monksdream 9 meses hace
CVAC new 52 week low
👍️0
Monksdream Monksdream 11 meses hace
CVAC new 52 week low
👍️0
Monksdream Monksdream 11 meses hace
CVAC new 52 week low
👍️0
mick mick 1 año hace
https://www.otcmarkets.com/stock/CVAC
👍️0
mick mick 1 año hace
https://www.otcmarkets.com/stock/CVAC
👍️0
mick mick 1 año hace
https://www.otcmarkets.com/stock/CVAC
👍️0
mick mick 1 año hace
https://www.otcmarkets.com/stock/CVAC
👍️0
mick mick 1 año hace
https://www.otcmarkets.com/stock/CVAC
👍️0
mick mick 1 año hace
CVAC
CureVac NV
8.99
0.09 (1.01%)
Volume: 232,857
Day Range: 8.73 - 9.15
Last Trade Time: 6:30:54 PM EDT
👍️0
Mr. Pearson Mr. Pearson 2 años hace
Big News coming soon... just be patient....
👍️0
mick mick 2 años hace
CVAC
CureVac NV
10.98
1.30 (13.43%)
Volume: 464,848
Day Range: 9.72 - 10.47
Last Trade Time: 7:53:28 PM EDT
👍️0
mick mick 2 años hace
CVAC
CureVac NV
10.98
1.30 (13.43%)
Volume: 464,848
Day Range: 9.72 - 10.47
Last Trade Time: 7:53:28 PM EDT
👍️0
mick mick 2 años hace
CVAC
CureVac NV
10.98
1.30 (13.43%)
Volume: 464,848
Day Range: 9.72 - 10.47
Last Trade Time: 7:53:28 PM EDT
👍️0
mick mick 2 años hace
CVAC
CureVac NV
12.23
0.80 (7.00%)
Volume: 2,433,695
Day Range: 11.02 - 12.36
Last Trade Time: 7:59:28 PM EDT
👍️0
mick mick 2 años hace
CVAC
CureVac NV
12.23
0.80 (7.00%)
Volume: 2,433,695
Day Range: 11.02 - 12.36
Last Trade Time: 7:59:28 PM EDT
👍️0
mick mick 2 años hace
CVAC
CureVac NV
9.15
-0.28 (-2.97%)
Volume: 373,244
Day Range: 9.06 - 9.49
Last Trade Time: 6:38:15 PM EDT
👍️0
mick mick 2 años hace
CVAC
CureVac NV
7.37
0.05 (0.68%)
Volume: 613,302
Day Range: 7.28 - 7.40
Last Trade Time: 7:50:44 PM EDT
👍️0
mick mick 2 años hace
CVAC
CureVac NV
7.79
-0.11 (-1.39%)
Volume: 227,150
Day Range: 7.66 - 8.13
Last Trade Time: 5:09:42 PM EDT
👍️0
mick mick 2 años hace
CVAC
CureVac NV
7.79
-0.11 (-1.39%)
Volume: 227,150
Day Range: 7.66 - 8.13
Last Trade Time: 5:09:42 PM EDT
👍️0
mick mick 2 años hace
CVAC
CureVac NV
7.79
-0.11 (-1.39%)
Volume: 227,150
Day Range: 7.66 - 8.13
Last Trade Time: 5:09:42 PM EDT
👍️0
mick mick 2 años hace
CVAC
CureVac NV
7.79
-0.11 (-1.39%)
Volume: 227,150
Day Range: 7.66 - 8.13
Last Trade Time: 5:09:42 PM EDT
👍️0
mick mick 2 años hace
CVAC
CureVac NV
8.50
-0.16 (-1.85%)
Volume: 641,450
Day Range: 8.52 - 8.68
Last Trade Time: 7:00:46 PM EST
👍️0
mick mick 2 años hace
CVAC
CureVac NV
11.06
-0.62 (-5.31%)
Volume: 537,147
Day Range: 11.01 - 11.83
Last Trade Time: 7:55:22 PM EST
👍️0
mick mick 2 años hace
it is relative CureVac (CVAC) Receives a Buy from Berenberg Bank
August 23 2022 - 09:55PM
TipRanks
Alert
Print
Share On Facebook
In a report released yesterday, Zhiqiang Shu from Berenberg Bank maintained a Buy rating on CureVac (CVAC - Research Report), with a price target of $45.00. The company's shares closed yesterday at $11.32.Shu covers the Healthcare sector, focusing on stocks such as Alnylam Pharma, Arcus Biosciences, and Sutro Biopharma. According to TipRanks, Shu has an average return of -21.0% and a 23.78% success rate on recommended stocks. Currently, the analyst consensus on CureVac is a Moderate Buy with an average price target of $28.50, implying a 151.77% upside from current levels.
https://www.tipranks.com/news/blurbs/curevac-cvac-receives-a-buy-from-berenberg-bank?utm_source=advfn.com&utm_medium=referral
👍️0
mick mick 2 años hace
CVAC
CureVac NV
6.60
-0.21 (-3.08%)
Volume: 387,429
Day Range: 6.58 - 6.99
Last Trade Time: 4:09:13 PM EST
👍️0
mick mick 2 años hace
i think $CVAC is ah buyout candidate /\

let's say $40
👍️0
mick mick 2 años hace
CVAC
CureVac NV
6.81
0.04 (0.59%)
Volume: 1,065,479
Day Range: 6.52 - 6.93
Last Trade Time: 4:46:47 PM EST
👍️0
mick mick 2 años hace
CVAC
CureVac NV
7.49
0.28 (3.88%)
Volume: 181,787
Day Range: 7.155 - 7.49
Bid: 6.13
Ask: 9.18
Last Trade Time: 4:13:18 PM EDT
Total Trades: 1,819
CVAC Detailed Quote
👍️0
mick mick 2 años hace
CVAC
CureVac NV
7.49
0.28 (3.88%)
Volume: 181,787
Day Range: 7.155 - 7.49
Bid: 6.13
Ask: 9.18
Last Trade Time: 4:13:18 PM EDT
Total Trades: 1,819
CVAC Detailed Quote
👍️0
mick mick 2 años hace
CVAC
CureVac N.V.
Ordinary Shares
9.84
-0.40

-3.90%

Delayed (15 Min) Trade Data: 04:00pm 08/31/2022
Overview
Quote
Company Profile
Security Details
News
Financials
Disclosure
Research
👍️0
mick mick 2 años hace
we don't show quote ?????
👍️0
mick mick 2 años hace
we don't show quote ?????
👍️0
mick mick 2 años hace
CureVac (CVAC) Receives a Buy from Berenberg Bank
August 23 2022 - 09:55PM
TipRanks
Alert
Print
Share On Facebook
In a report released yesterday, Zhiqiang Shu from Berenberg Bank maintained a Buy rating on CureVac (CVAC - Research Report), with a price target of $45.00. The company's shares closed yesterday at $11.32.Shu covers the Healthcare sector, focusing on stocks such as Alnylam Pharma, Arcus Biosciences, and Sutro Biopharma. According to TipRanks, Shu has an average return of -21.0% and a 23.78% success rate on recommended stocks. Currently, the analyst consensus on CureVac is a Moderate Buy with an average price target of $28.50, implying a 151.77% upside from current levels.
https://www.tipranks.com/news/blurbs/curevac-cvac-receives-a-buy-from-berenberg-bank?utm_source=advfn.com&utm_medium=referral
👍️0
mick mick 3 años hace
CVAC
CureVac NV
12.62
-0.03 (-0.24%)
Volume: 276,718
Day Range: 12.39 - 12.79
Bid: 12.60
Ask: 13.18
Last Trade Time: 4:57:18 PM EDT
Total Trades: 3,775
CVAC Detailed Quote
👍️0
sdy sdy 3 años hace
Interesting new Beneficial Owners recently. Taken an entry position today.
Looks like Covid-19 vaccines still hold prominent place in biotech research: "CureVac and GSK's second-generation vaccine candidate targeting two recent COVID-19 variants has been shown to be highly effective in preclinical studies on mice, CureVac said, as it seeks to catch up with rivals' development work." https://finance.yahoo.com/news/1-curevac-gsks-experimental-covid-124419805.html
👍️0
mick mick 3 años hace
CureVac NV (CVAC)
18.18 ? -0.65 (-3.45%)
Volume: 402,327 @06/03/22 6:58:05 PM EDT
Bid Ask Day's Range
17.61 20.1 17.56 - 18.58
CVAC Detailed Quote
👍️0
mick mick 3 años hace
CureVac NV (CVAC)
18.18 ? -0.65 (-3.45%)
Volume: 402,327 @06/03/22 6:58:05 PM EDT
Bid Ask Day's Range
17.61 20.1 17.56 - 18.58
CVAC Detailed Quote
👍️0
mick mick 3 años hace
https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-contrafect-cfrx-curevac-cvac?utm_source=advfn.com&utm_medium=referral
👍️0
mick mick 3 años hace
https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-contrafect-cfrx-curevac-cvac?utm_source=advfn.com&utm_medium=referral
👍️0
mick mick 3 años hace
CureVac NV (CVAC)
17.205 ? 0.625 (3.77%)
Volume: 164,845 @04/29/22 1:27:43 PM EDT
Bid Ask Day's Range
17.2 17.25 16.47 - 17.44
CVAC Detailed Quote
👍️0
mick mick 3 años hace
CureVac NV (CVAC)
15.69 ? -1.08 (-6.44%)
Volume: 305,719 @03/11/22 5:11:50 PM EST
Bid Ask Day's Range
15.7 16.66 15.68 - 17.225
CVAC Detailed Quote
👍️0
mick mick 3 años hace
CureVac NV (CVAC)
18.19 ? 0.05 (0.28%)
Volume: 587,579 @02/04/22 5:09:58 PM EST
Bid Ask Day's Range
17.05 19.74 17.7685 - 18.61
CVAC Detailed Quote
👍️0
mick mick 3 años hace
https://www.otcmarkets.com/stock/CVAC
👍️0
mick mick 3 años hace
https://www.otcmarkets.com/stock/CVAC
👍️0
2times2 2times2 3 años hace
CureVac Says Preclinical Trial Shows Antibody Levels of COVID-19 Vaccine Candidate CV2CoV 'Highly Comparable' With Pfizer's mRNA Vaccine
MT NEWSWIRES 3:11 PM ET 11/18/2021

03:11 PM EST, 11/18/2021 (MT Newswires) -- CureVac(CVAC) said Thursday the extended preclinical study of the second-generation vaccine candidate, CV2CoV, showed that neutralizing antibody levels after full vaccination of animals were "highly comparable" with Pfizer (PFE) and BioNTech's (BNTX) licensed mRNA vaccine, Comirnaty.

CureVac (CVAC) is developing CV2CoV in partnership with GlaxoSmithKline (GSK). Animals were vaccinated with either 12 micrograms of CV2CoV or a 30 microgram standard dose of Comirnaty.

Data showed that targeted optimizations of a non-chemically modified mRNA can significantly improve immune responses in a preclinical model.

👍️0
mick mick 3 años hace
CureVac NV (CVAC)
38.0 ? -3.47 (-8.37%)
Volume: 1,621,942 @11/05/21 7:55:54 PM EDT
Bid Ask Day's Range
38.02 38.19 36.32 - 39.33
CVAC Detailed Quote
👍️0

Su Consulta Reciente

NASDAQ
CVAC
CureVac NV
NEO
GS
Goldman Sachs CDR
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios